Search

Search Constraints

You searched for: Author/Creator Mileshkin, Linda

Search Results

32. ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum‐sensitive ovarian cancer following a response to platinum‐based chemotherapy. Issue 1 (January 2021)

33. Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary. Issue 1 (31st January 2023)

34. Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. (1st February 2017)

36. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. Issue 6 (1st December 2020)

37. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. Issue 6 (1st December 2020)

38. Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary. Issue 4 (12th November 2013)

39. Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary. Issue 4 (December 2013)